1175 / 1578
/
C O N C L U S I O N S
•
SBRT in the metastatic situation is growing
rapidly
•
SBRT is frequently combined with novel
drugs
•
Lack of efficacy and especially safety data for
many drugs and treatment sites
Ø
Further research needed
07.09.17
ESTRO SBRT COURSE 2017 - Matthias Guckenberger
47